Steven Bauer, M.D., a seasoned family medicine doctor, has been a fixture in the Charlotte, North Carolina, healthcare landscape for nearly twenty years. He founded Ballantyne Medical Associates in 2007, establishing a practice that became a regional leader. The practice is particularly noted for its early adoption of REGEN-COV monoclonal antibody therapy during the COVID-19 pandemic.
Dr. Bauer's career is marked by his extensive involvement in critical FDA clinical trials, particularly those targeting COVID-19 therapeutics. His research interests are broad, covering hormone replacement therapy for men and women, innovative approaches to opioid addiction treatment, and the care of vascular endothelium.
Beyond his clinical and research duties, Steven Bauer DO is passionate about various hobbies that enrich his life, including culinary exploration, wine, and international travel. His dedication to community service is exemplified by his longstanding commitment to medical education, where he has been a volunteer educator since his career began.
Steven leads Ballantyne Medical Associates as a comprehensive healthcare facility that offers primary care as well as specialized treatments such as hormone replacement therapy and advanced aesthetic services. His approach to medicine is holistic, ensuring that each patient’s treatment plan is tailored to their specific health needs.
Education is a cornerstone of his practice. Dr. Bauer and his team are dedicated to making sure that patients are well-informed about their health, using clear and straightforward language to explain medical conditions and treatments.
Dr. Steven Bauer’s academic path included pre-med studies at North Carolina State University and a medical degree from the New York Institute of Technology. He completed his residency at Good Samaritan Hospital Medical Center in New York, where he was elected Chief Resident. He then practiced for a decade in Long Island, incorporating roles such as medical educator and HIV disease specialist.